Veracyte Inc at Piper Sandler Healthcare Conference (Virtual) - Pre-recorded Fireside Chat Transcript
Hello, and welcome to the 32nd Annual Piper Sandler Health Care Conference. I'm Steven Mah, Senior Research Analyst at Piper Sandler covering diagnostics. I'm very pleased to have with us today Bonnie Anderson, CEO of Veracyte. Bonnie, for the benefit of those who are new to the Veracyte story, could you give us an overview of Veracyte before we get into Q&A?
Absolutely. Steve, thanks so much for the opportunity to join you in the conference today. It's really our pleasure to be here.
I want to just provide a broad-based overview of where Veracyte is. We are a global diagnostics company today leveraging deep genomic insights to transform care for patients at every step of their journey. From the beginning of the company's funding, we've always focused heavily on answering clinical questions that have strong relevancy that, if answered, are going to create a great benefit for the patient, but
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |